Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Study of CS-3150 in Patients With Severe Hypertension | Clinical Trials | Clareo Health

Back to search

COMPLETEDPhase 3

Study of CS-3150 in Patients With Severe Hypertension

A Study to Evaluate Efficacy and Safety of CS-3150 in Japanese Patients With Severe Hypertension (Grade III)

NCT02808026•Daiichi Sankyo Co., Ltd.

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Severe Hypertension

Interventions

CS-3150

Locations

Japan

Locations (1)

Sapporo, Japan

Key Dates

Start Date

June 1, 2016

Primary Completion Date

February 1, 2017

Completion Date

February 1, 2017

Last Updated

December 21, 2018

Sponsors

Lead Sponsor

Daiichi Sankyo Co., Ltd.

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 21, 2018Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions